RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Beijing Sun-Novo Pharmaceutical Research Co Stock

Beijing Sun-Novo Pharmaceutical Research Co ROA 2024

Beijing Sun-Novo Pharmaceutical Research Co ROA

0.1

Ticker

688621.SS

ISIN

CNE100005139

In 2024, Beijing Sun-Novo Pharmaceutical Research Co's return on assets (ROA) was 0.1, a -6.93% increase from the 0.11 ROA in the previous year.

Beijing Sun-Novo Pharmaceutical Research Co Aktienanalyse

What does Beijing Sun-Novo Pharmaceutical Research Co do?

Beijing Sun-Novo Pharmaceutical Research Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Beijing Sun-Novo Pharmaceutical Research Co's Return on Assets (ROA)

Beijing Sun-Novo Pharmaceutical Research Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Beijing Sun-Novo Pharmaceutical Research Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Beijing Sun-Novo Pharmaceutical Research Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Beijing Sun-Novo Pharmaceutical Research Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Beijing Sun-Novo Pharmaceutical Research Co stock

What is the Return on Assets (ROA) of Beijing Sun-Novo Pharmaceutical Research Co this year?

The Return on Assets (ROA) of Beijing Sun-Novo Pharmaceutical Research Co is 0.1 undefined this year.

What was the ROA of Beijing Sun-Novo Pharmaceutical Research Co compared to the previous year?

The ROA of Beijing Sun-Novo Pharmaceutical Research Co has increased by -6.93% compared to the previous year.

What consequences do high ROA have for investors of Beijing Sun-Novo Pharmaceutical Research Co?

A high ROA is advantageous for investors of Beijing Sun-Novo Pharmaceutical Research Co, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Beijing Sun-Novo Pharmaceutical Research Co?

A low ROA can be unfavorable for investors of Beijing Sun-Novo Pharmaceutical Research Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Beijing Sun-Novo Pharmaceutical Research Co affect the company?

An increase in ROA of Beijing Sun-Novo Pharmaceutical Research Co can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Beijing Sun-Novo Pharmaceutical Research Co impact the company?

A reduction in the ROA of Beijing Sun-Novo Pharmaceutical Research Co can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Beijing Sun-Novo Pharmaceutical Research Co?

Some factors that can influence the ROA of Beijing Sun-Novo Pharmaceutical Research Co include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Beijing Sun-Novo Pharmaceutical Research Co important for investors?

The ROA of Beijing Sun-Novo Pharmaceutical Research Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Beijing Sun-Novo Pharmaceutical Research Co take to improve ROA?

To improve ROA, Beijing Sun-Novo Pharmaceutical Research Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Beijing Sun-Novo Pharmaceutical Research Co pay?

Over the past 12 months, Beijing Sun-Novo Pharmaceutical Research Co paid a dividend of 0.43 CNY . This corresponds to a dividend yield of about 1.14 %. For the coming 12 months, Beijing Sun-Novo Pharmaceutical Research Co is expected to pay a dividend of 0.49 CNY.

What is the dividend yield of Beijing Sun-Novo Pharmaceutical Research Co?

The current dividend yield of Beijing Sun-Novo Pharmaceutical Research Co is 1.14 %.

When does Beijing Sun-Novo Pharmaceutical Research Co pay dividends?

Beijing Sun-Novo Pharmaceutical Research Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Beijing Sun-Novo Pharmaceutical Research Co?

Beijing Sun-Novo Pharmaceutical Research Co paid dividends every year for the past 5 years.

What is the dividend of Beijing Sun-Novo Pharmaceutical Research Co?

For the upcoming 12 months, dividends amounting to 0.49 CNY are expected. This corresponds to a dividend yield of 1.31 %.

In which sector is Beijing Sun-Novo Pharmaceutical Research Co located?

Beijing Sun-Novo Pharmaceutical Research Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Beijing Sun-Novo Pharmaceutical Research Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Beijing Sun-Novo Pharmaceutical Research Co from 7/9/2024 amounting to 0.165 CNY, you needed to have the stock in your portfolio before the ex-date on 7/9/2024.

When did Beijing Sun-Novo Pharmaceutical Research Co pay the last dividend?

The last dividend was paid out on 7/9/2024.

What was the dividend of Beijing Sun-Novo Pharmaceutical Research Co in the year 2023?

In the year 2023, Beijing Sun-Novo Pharmaceutical Research Co distributed 0.189 CNY as dividends.

In which currency does Beijing Sun-Novo Pharmaceutical Research Co pay out the dividend?

The dividends of Beijing Sun-Novo Pharmaceutical Research Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Beijing Sun-Novo Pharmaceutical Research Co

Our stock analysis for Beijing Sun-Novo Pharmaceutical Research Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Beijing Sun-Novo Pharmaceutical Research Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.